Department of Neuropsychiatry University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama, 930-0194, Japan.
Department of Physiology, Showa University School of Medicine, Tokyo, Japan.
Eur Arch Psychiatry Clin Neurosci. 2018 Oct;268(7):689-698. doi: 10.1007/s00406-017-0845-3. Epub 2017 Oct 25.
Odor identification deficits are well documented in patients with schizophrenia, but it remains unclear whether individuals at clinical high-risk for psychosis exhibit similar changes and whether their olfactory function is related to social/cognitive functions and symptomatology. In this study, we investigated odor detection sensitivity and identification ability in 32 individuals with at-risk mental state (ARMS), 59 schizophrenia patients, and 169 healthy controls using a T&T olfactometer. The ARMS and schizophrenia subjects were administered the Brief Assessment of Cognition in Schizophrenia (BACS), the Schizophrenia Cognition Rating Scale (SCoRS), and the Social and Occupational Functioning Assessment Scale (SOFAS) to assess their cognitive and social functions, and the Positive and Negative Syndrome Scale (PANSS) for clinical symptoms. Both the ARMS and schizophrenia subjects had lower odor identification ability when compared with healthy controls, while no significant difference was found in the odor detection sensitivity. The lower odor identification ability in the ARMS group correlated with the severity of negative symptoms and weakly correlated with lower performance on the BACS verbal fluency test. The olfactory measures of schizophrenia patients did not correlate with illness duration, medication, symptom severity, and social and cognitive functions. For the ARMS and schizophrenia groups, the olfactory measures did not correlate with the SOFAS and SCoRS scores. These findings suggest that high-risk subjects for psychosis already show odor identification deficits similar to those observed in schizophrenia patients, which probably reflect a biological trait related to vulnerability to psychosis.
嗅觉识别障碍在精神分裂症患者中已有充分记录,但目前尚不清楚处于精神病高危状态的个体是否表现出类似的变化,以及他们的嗅觉功能是否与社会/认知功能和症状有关。在这项研究中,我们使用 T&T 嗅觉计对 32 名处于高危精神状态(ARMS)的个体、59 名精神分裂症患者和 169 名健康对照者进行了嗅觉检测敏感性和识别能力的研究。对 ARMS 和精神分裂症患者进行了简明认知评估(BACS)、精神分裂症认知评定量表(SCoRS)和社会和职业功能评估量表(SOFAS),以评估他们的认知和社会功能,以及阳性和阴性综合征量表(PANSS)进行临床症状评估。与健康对照组相比,ARMS 和精神分裂症患者的嗅觉识别能力均较低,而嗅觉检测敏感性无明显差异。ARMS 组较低的嗅觉识别能力与阴性症状的严重程度相关,与 BACS 言语流畅性测试的较低表现呈弱相关。精神分裂症患者的嗅觉测量值与疾病持续时间、药物、症状严重程度以及社会和认知功能无关。对于 ARMS 和精神分裂症组,嗅觉测量值与 SOFAS 和 SCoRS 评分无关。这些发现表明,精神病高危人群已经表现出与精神分裂症患者相似的嗅觉识别缺陷,这可能反映了与精神病易感性相关的生物学特征。